Aranesp is the trade name for Darbepoetin alfa, a synthetic version of erythropoietin, which stimulates the production of red blood cells. Aranesp has been used since its approval by the U.S. Food and Drug Administration (FDA) in 2001 to treat patients with anemia, as well as chronic renal failure. It has been frequently prescribed to individuals suffering anemia as a byproduct of chemotherapy.
The FDA has required black box warnings on all sales of Darbepoetin alfa in the United States, citing a number of potential adverse health risks, including:
If you experienced side effects after being prescribed Aranesp, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Factors Often Involved in Motor Vehicle Accidents According to data collected by the National Highway Traffic Safety Ad... Read More
What Factors Are Involved? | How the Court Determines the Amount Though it's less common than it was generations ago, a... Read More
Taking the Right Steps to Get the Outcome You Want in a Custody Dispute Whether you're currently going through the divo... Read More
How It Works